Postpoliomyelitis Syndrome
8
2
2
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
12.5%
1 terminated out of 8 trials
75.0%
-11.5% vs benchmark
25%
2 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Non-invasive Spinal, Cortical, and Sensorimotor Biomarkers in Motor Neurone Disease
Impairments of Neuro-muscular Communication in Motor-Neuron Disease: A Bio-Marker for Early and Personalised Diagnosis
A Randomized, Double Blind, Placebo Controlled Trial L-carnitine and Piracetam in the Treatment of Weakness, Muscle Fatigue and Muscle Pain in the Postpoliomyelitis Syndrome
Arm Cycling to Improve Fitness in Polio Survivors
Modafinil to Treat Fatigue in Post-Polio Syndrome
Study of "Post-Polio Syndrome"
Electromyography to Diagnose Neuromuscular Disorders
Study of Mental Fatigue in Polio Survivors